Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Canaccord raises target for Trainline as strike headwinds ease

(Sharecast News) - Canaccord Genuity has hiked its target price for Trainline ahead of the booking platform's trading next month after pencilling in a less-than-expected impact from recent rail strikes. There were 24 strike days in Trainline's current financial year ending 28 February 2024, which Canaccord estimates had a negative impact of £120m on net ticket sales, equal to 2% of the full-year number.

"With only one UK Rail union (ASLEF) still striking and at a reducing rate, we believe the negative impact from strikes is reducing," the broker said.

Meanwhile, Canaccord said that Trainline's international operations are becoming "less of a drag" with strong growth seen in Spain and Italy. A reduction of marketing spend in Germany and France due to less new carrier competition should also help earnings too.

The broker has lifted its EBITDA forecasts for the financial years ending 2024, 2025 and 2026 by around 2%, helping its target price for the stock up to 428p, from 371p previously, as it maintained a 'buy' rating.

Canaccord said Trainline has significant future growth drivers over the the medium-to-long term, which include: "1) online shift across the UK and Europe; 2) product and marketing leadership resulting in continued market share gains; 3) total addressable market expansion from the deregulation of European rail travel; 4) innovation such as e-tickets and digital season tickets driving growth; and 5) RPI linked rail pricing."

The stock was down 1% at 308.2p by 1051 GMT.

Share this article

Related Sharecast Articles

Endeavour pours first gold at Senegal mine
(Sharecast News) - Endeavour Mining said it had poured first gold from the Sabodala-Massawa BIOX Expansion project in Senegal on April 18.
Wood Group creates new chief strategy officer role
(Sharecast News) - Consulting and engineering business Wood Group has created a new executive role of chief strategy officer to look after things like sustainability and corporate development.
AstraZeneca makes progress with two breast cancer treatments
(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.
Kosmos Energy refinances reserve-based lending facility
(Sharecast News) - Kosmos Energy announced the refinancing of its reserve-based lending (RBL) facility on Monday, with its final maturity now set for December 2029.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.